Scott E. Woodman, Ph.D.
Affiliations: | 2004 | Yeshiva University, New York, NY, United States |
Area:
Molecular Biology, Animal Physiology BiologyGoogle:
"Scott Woodman"Mean distance: 6635.5
Parents
Sign in to add mentor| Michael P. Lisanti | grad student | 2004 | Yeshiva University | |
| (A characterization of caveolins/caveolae in cardiac and smooth muscle tissues.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| De Souza AP, Cohen AW, Park DS, et al. (2005) MR imaging of caveolin gene-specific alterations in right ventricular wall thickness. Magnetic Resonance Imaging. 23: 61-8 |
| Woodman SE, Sotgia F, Galbiati F, et al. (2004) Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 62: 538-43 |
| Woodman SE, Cheung MW, Tarr M, et al. (2004) Urogenital alterations in aged male caveolin-1 knockout mice. The Journal of Urology. 171: 950-7 |
| Sotgia F, Bonuccelli G, Minetti C, et al. (2003) Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. The American Journal of Pathology. 163: 2619-34 |
| Bonuccelli G, Sotgia F, Schubert W, et al. (2003) Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. The American Journal of Pathology. 163: 1663-75 |
| Sotgia F, Woodman SE, Bonuccelli G, et al. (2003) Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease. American Journal of Physiology. Cell Physiology. 285: C1150-60 |
| Woodman SE, Ashton AW, Schubert W, et al. (2003) Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. The American Journal of Pathology. 162: 2059-68 |
| Frank PG, Woodman SE, Park DS, et al. (2003) Caveolin, caveolae, and endothelial cell function. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1161-8 |
| Cohen AW, Park DS, Woodman SE, et al. (2003) Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. American Journal of Physiology. Cell Physiology. 284: C457-74 |
| Razani B, Woodman SE, Lisanti MP. (2002) Caveolae: from cell biology to animal physiology. Pharmacological Reviews. 54: 431-67 |